GUID: 739EBAOF-FOFE-4268-Al17D-EB157F1369ECProposed Medicare & Medicaid Restructuring Options with Large Benefit Cuts and Tax Increases
1 duplicate copy in the archive
Cannabis Investment Report – Basic Endocannabinoid Overview
Title Matchkaggle-ho-024654
Case Filed-27316House OversightCannabis Investment Report – Basic Endocannabinoid Overview
November 11, 20251p1 persons
Case File
d-27316House OversightCannabis Investment Report – Basic Endocannabinoid Overview
Other
The passage is an educational overview of the human endocannabinoid system from a 2017 investment report. It contains no specific names, transactions, dates, or allegations linking powerful actors to Describes CB1 and CB2 receptors and their physiological roles. Mentions potential medical applications of cannabinoids. Identifies Ackrell Capital, LLC as the report issuer (FINRA/SIPC member).
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024654
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.